Advances in triterpene drug discovery

AbstractTriterpenes are structurally complex natural products with promising therapeutic properties. Recalcitrance to chemical synthesis has hindered their use in drug development. Recent advances now make it possible to access and harness triterpene structural diversity using engineering biology ap...

Full description

Saved in:
Bibliographic Details
Published inTrends in pharmacological sciences (Regular ed.) Vol. 45; no. 11; pp. 964 - 968
Main Authors Goddard, Zoë R, Searcey, Mark, Osbourn, Anne
Format Journal Article
LanguageEnglish
Published England 01.11.2024
Subjects
Advanced Basic Science
Animals
Biological Products - chemistry
Biological Products - pharmacology
Drug Discovery - methods
Humans
Triterpenes - chemistry
Triterpenes - pharmacology
plant natural products
metabolic engineering
drug discovery
triterpenes
Online AccessGet full text

Cover

Abstract AbstractTriterpenes are structurally complex natural products with promising therapeutic properties. Recalcitrance to chemical synthesis has hindered their use in drug development. Recent advances now make it possible to access and harness triterpene structural diversity using engineering biology approaches, enabling the discovery and optimisation of a new generation of drug leads.
AbstractList AbstractTriterpenes are structurally complex natural products with promising therapeutic properties. Recalcitrance to chemical synthesis has hindered their use in drug development. Recent advances now make it possible to access and harness triterpene structural diversity using engineering biology approaches, enabling the discovery and optimisation of a new generation of drug leads.
Triterpenes are structurally complex natural products with promising therapeutic properties. Recalcitrance to chemical synthesis has hindered their use in drug development. Recent advances now make it possible to access and harness triterpene structural diversity using engineering biology approaches, enabling the discovery and optimisation of a new generation of drug leads.Triterpenes are structurally complex natural products with promising therapeutic properties. Recalcitrance to chemical synthesis has hindered their use in drug development. Recent advances now make it possible to access and harness triterpene structural diversity using engineering biology approaches, enabling the discovery and optimisation of a new generation of drug leads.
Triterpenes are structurally complex natural products with promising therapeutic properties. Recalcitrance to chemical synthesis has hindered their use in drug development. Recent advances now make it possible to access and harness triterpene structural diversity using engineering biology approaches, enabling the discovery and optimisation of a new generation of drug leads.
Author Searcey, Mark
Osbourn, Anne
Goddard, Zoë R
Author_xml – sequence: 1
  fullname: Goddard, Zoë R
– sequence: 2
  fullname: Searcey, Mark
– sequence: 3
  fullname: Osbourn, Anne
BackLink https://www.ncbi.nlm.nih.gov/pubmed/39482199$$D View this record in MEDLINE/PubMed
BookMark eNp9kU1LxDAQhoOsuB_6BzxIL4KXrvlq01wEWfyCBQ8qeAttOpXUblqTdmH_vSm7e_HgKTDzvEPmmTma2NYCQpcELwkm6W297E3nlxRTHgpLjNkJmpFMsJgJlkzQLEBJnBIupmjufY0DwSg5Q1MmeUaJlDN0fV9uc6vBR8ZGvTM9uA4sRKUbvqLSeN1uwe3O0WmVNx4uDu8CfTw-vK-e4_Xr08vqfh1rjmkfMy1ZKTFhFUkKLdJEUgGSFyCopCAh1aHLZeinSVKFJmdlIpKcFKIgGdNsgW72czvX_gzge7UJX4CmyS20g1eMUIYFFRkO6NUBHYoNlKpzZpO7nTquFoBsD2jXeu-gUtr0eW9a27vcNIpgNVpUtRotqtHiWBsdLRD9Ez1O_zd0tw9BELQ14JRujDU6b75hB75uB2eDO0WUpwqrt_E4420ox5gS9sl-Ac2wiTw
CitedBy_id crossref_primary_10_1016_j_pbi_2025_102701
crossref_primary_10_1007_s11274_025_04301_1
crossref_primary_10_32604_phyton_2025_059581
Cites_doi 10.1038/s41586-023-05856-5
10.3390/ijms241310695
10.1021/acs.jmedchem.2c00879
10.1039/D4CB00062E
10.1016/j.apsb.2021.12.008
10.1038/s41586-024-07345-9
10.1039/D3CC01009K
10.1021/acs.jnatprod.4c00581
10.1016/j.ymben.2017.06.012
10.1016/j.bmcl.2020.127661
10.1038/s41586-024-07487-w
10.1021/acs.jmedchem.5b01409
10.1021/acs.jmedchem.3c00501
10.1038/s41589-023-01538-5
10.1093/nar/gkab1061
10.1007/s40265-023-01874-9
10.1007/s40265-021-01571-5
10.1038/s42256-022-00580-7
ContentType Journal Article
Copyright The Author(s)
Copyright © 2024 The Author(s). Published by Elsevier Ltd.. All rights reserved.
Copyright_xml – notice: The Author(s)
– notice: Copyright © 2024 The Author(s). Published by Elsevier Ltd.. All rights reserved.
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1016/j.tips.2024.10.003
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList
MEDLINE - Academic
MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Pharmacy, Therapeutics, & Pharmacology
EISSN 1873-3735
EndPage 968
ExternalDocumentID 39482199
10_1016_j_tips_2024_10_003
1_s2_0_S016561472400213X
Genre Research Support, Non-U.S. Gov't
Journal Article
Review
GroupedDBID ---
--K
--M
.1-
.55
.FO
.GJ
.~1
0R~
123
1B1
1CY
1KJ
1P~
1RT
1~.
1~5
29Q
4.4
457
4G.
53G
5VS
7-5
71M
8P~
8WZ
9JM
A6W
AACTN
AAEDT
AAEDW
AAIKJ
AAKOC
AALRI
AAMRU
AAOAW
AAQFI
AAXKI
AAXLA
AAXUO
AAYOK
ABCQJ
ABFNM
ABFRF
ABJNI
ABLJU
ABMAC
ABOCM
ABXDB
ABZDS
ACDAQ
ACGFO
ACGFS
ACIUM
ACRLP
ADBBV
ADEZE
AEBSH
AEFWE
AEIPS
AEKER
AENEX
AEVXI
AFCTW
AFKWA
AFRHN
AFTJW
AFXIZ
AGHFR
AGUBO
AGWIK
AGYEJ
AHHHB
AIEXJ
AIKHN
AITUG
AJOXV
AJUYK
AKRWK
ALCLG
ALMA_UNASSIGNED_HOLDINGS
AMFUW
AMRAJ
ANKPU
ASPBG
AVWKF
AXJTR
AZFZN
BKOJK
BLXMC
CS3
DU5
EBS
EFJIC
EJD
EO8
EO9
EP2
EP3
F5P
FDB
FEDTE
FGOYB
FIRID
FNPLU
FYGXN
G-2
G-Q
GBLVA
HMQ
HMT
HVGLF
HZ~
IH2
IHE
J1W
KOM
M2V
M34
M41
MO0
MOBAO
MVM
N9A
O-L
O9-
O9.
OAUVE
OGGZJ
OK~
OZT
P-8
P-9
P2P
PC.
Q38
R2-
RIG
ROL
RPZ
RXW
SCC
SDF
SDG
SDP
SES
SEW
SNS
SPCBC
SPT
SSN
SSP
SSZ
T5K
TAE
WUQ
X7M
XJT
Z5R
ZGI
ZKB
ZXP
~02
~G-
AATTM
AAYWO
AAYXX
ACVFH
ADCNI
AEUPX
AFPUW
AGCQF
AGRNS
AIGII
AIIUN
AKBMS
AKYEP
APXCP
BNPGV
CITATION
SSH
CGR
CUY
CVF
ECM
EFKBS
EIF
NPM
7X8
ID FETCH-LOGICAL-c402t-3c93d9013f15bc765927e94be7292e9e6cd904913f655f92743d575a1b7b183c3
ISSN 0165-6147
1873-3735
IngestDate Mon Jul 21 12:02:18 EDT 2025
Wed Aug 13 02:10:04 EDT 2025
Tue Jul 01 02:55:49 EDT 2025
Thu Apr 24 23:11:39 EDT 2025
Tue Feb 25 19:54:18 EST 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 11
Keywords plant natural products
metabolic engineering
drug discovery
triterpenes
Language English
License Copyright © 2024 The Author(s). Published by Elsevier Ltd.. All rights reserved.
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c402t-3c93d9013f15bc765927e94be7292e9e6cd904913f655f92743d575a1b7b183c3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
ObjectType-Review-3
content type line 23
ORCID 0000-0003-2195-5810
OpenAccessLink https://www.clinicalkey.es/playcontent/1-s2.0-S016561472400213X
PMID 39482199
PQID 3123072780
PQPubID 23479
PageCount 5
ParticipantIDs proquest_miscellaneous_3123072780
pubmed_primary_39482199
crossref_citationtrail_10_1016_j_tips_2024_10_003
crossref_primary_10_1016_j_tips_2024_10_003
elsevier_clinicalkeyesjournals_1_s2_0_S016561472400213X
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2024-11-01
PublicationDateYYYYMMDD 2024-11-01
PublicationDate_xml – month: 11
  year: 2024
  text: 2024-11-01
  day: 01
PublicationDecade 2020
PublicationPlace England
PublicationPlace_xml – name: England
PublicationTitle Trends in pharmacological sciences (Regular ed.)
PublicationTitleAlternate Trends Pharmacol Sci
PublicationYear 2024
References Martin (10.1016/j.tips.2024.10.003_bb0040) 2024; 20
Regueiro-Ren (10.1016/j.tips.2024.10.003_bb0050) 2022; 65
Reed (10.1016/j.tips.2024.10.003_bb0035) 2017; 42
Lee (10.1016/j.tips.2024.10.003_bb0020) 2021; 81
Shen (10.1016/j.tips.2024.10.003_bb0065) 2024; 5
Martín-Acosta (10.1016/j.tips.2024.10.003_bb0060) 2022; 12
Apgar (10.1016/j.tips.2024.10.003_bb0070) 2021; 32
Brown (10.1016/j.tips.2024.10.003_bb0005) 2016; 59
Varadi (10.1016/j.tips.2024.10.003_bb0080) 2022; 50
Heise (10.1016/j.tips.2024.10.003_bb0055) 2023; 24
Ross (10.1016/j.tips.2024.10.003_bb0090) 2021; 4
Lee (10.1016/j.tips.2024.10.003_bb0015) 2023; 83
Hu (10.1016/j.tips.2024.10.003_bb0075) 2023; 616
McInturff (10.1016/j.tips.2024.10.003_bb0025) 2023; 66
Domingo-Fernández (10.1016/j.tips.2024.10.003_bb0010) 2024; 87
Abramson (10.1016/j.tips.2024.10.003_bb0085) 2024; 630
Liu (10.1016/j.tips.2024.10.003_bb0045) 2024; 629
Alekseychuk (10.1016/j.tips.2024.10.003_bb0030) 2023; 59
References_xml – volume: 616
  start-page: 190
  year: 2023
  ident: 10.1016/j.tips.2024.10.003_bb0075
  article-title: Structural and mechanistic insights into fungal β-1,3-glucan synthase FKS1
  publication-title: Nature
  doi: 10.1038/s41586-023-05856-5
– volume: 24
  start-page: 10695
  year: 2023
  ident: 10.1016/j.tips.2024.10.003_bb0055
  article-title: Mitochondria-targeting 1,5-diazacyclooctane-spacered triterpene rhodamine conjugates exhibit cytotoxicity at sub-nanomolar concentration against breast cancer cells
  publication-title: Int. J. Mol. Sci.
  doi: 10.3390/ijms241310695
– volume: 65
  start-page: 11927
  year: 2022
  ident: 10.1016/j.tips.2024.10.003_bb0050
  article-title: The discovery of GSK3640254, a next-generation inhibitor of HIV-1 maturation
  publication-title: J. Med. Chem.
  doi: 10.1021/acs.jmedchem.2c00879
– volume: 5
  start-page: 751
  year: 2024
  ident: 10.1016/j.tips.2024.10.003_bb0065
  article-title: Natural triterpenoid-aided identification of the druggable interface of HMGB1 occupied by TLR4
  publication-title: RSC Chem. Biol.
  doi: 10.1039/D4CB00062E
– volume: 12
  start-page: 2406
  year: 2022
  ident: 10.1016/j.tips.2024.10.003_bb0060
  article-title: A clickable photoaffinity probe of betulinic acid identifies tropomyosin as a target
  publication-title: Acta Pharm. Sin. B
  doi: 10.1016/j.apsb.2021.12.008
– volume: 629
  start-page: 937
  year: 2024
  ident: 10.1016/j.tips.2024.10.003_bb0045
  article-title: Complete biosynthesis of QS-21 in engineered yeast
  publication-title: Nature
  doi: 10.1038/s41586-024-07345-9
– volume: 59
  start-page: 6811
  year: 2023
  ident: 10.1016/j.tips.2024.10.003_bb0030
  article-title: Biogenetic space-guided synthesis of rearranged terpenoids
  publication-title: Chem. Commun. (Camb.)
  doi: 10.1039/D3CC01009K
– volume: 87
  start-page: 1844
  year: 2024
  ident: 10.1016/j.tips.2024.10.003_bb0010
  article-title: Natural products have increased rates of clinical trial success throughout the drug development process
  publication-title: J. Nat. Prod.
  doi: 10.1021/acs.jnatprod.4c00581
– volume: 42
  start-page: 185
  year: 2017
  ident: 10.1016/j.tips.2024.10.003_bb0035
  article-title: A translational synthetic biology platform for rapid access to gram-scale quantities of novel drug-like molecules
  publication-title: Metab. Eng.
  doi: 10.1016/j.ymben.2017.06.012
– volume: 32
  year: 2021
  ident: 10.1016/j.tips.2024.10.003_bb0070
  article-title: Ibrexafungerp: an orally active β-1,3-glucan synthesis inhibitor
  publication-title: Bioorg. Med. Chem. Lett.
  doi: 10.1016/j.bmcl.2020.127661
– volume: 630
  start-page: 493
  year: 2024
  ident: 10.1016/j.tips.2024.10.003_bb0085
  article-title: Accurate structure prediction of biomolecular interactions with AlphaFold3
  publication-title: Nature
  doi: 10.1038/s41586-024-07487-w
– volume: 59
  start-page: 4443
  year: 2016
  ident: 10.1016/j.tips.2024.10.003_bb0005
  article-title: Analysis of past and present synthetic methodologies on medicinal chemistry: where have all the new reactions gone?
  publication-title: J. Med. Chem.
  doi: 10.1021/acs.jmedchem.5b01409
– volume: 66
  start-page: 10150
  year: 2023
  ident: 10.1016/j.tips.2024.10.003_bb0025
  article-title: Synthetic approaches to the new drugs approved during 2021
  publication-title: J. Med. Chem.
  doi: 10.1021/acs.jmedchem.3c00501
– volume: 20
  start-page: 493
  year: 2024
  ident: 10.1016/j.tips.2024.10.003_bb0040
  article-title: Complete biosynthesis of the potent vaccine adjuvant QS-21
  publication-title: Nat. Chem. Biol.
  doi: 10.1038/s41589-023-01538-5
– volume: 50
  start-page: D439
  year: 2022
  ident: 10.1016/j.tips.2024.10.003_bb0080
  article-title: Alphafold protein structure database: massively expanding the structural coverage of protein-sequence space with high-accuracy models
  publication-title: Nucleic Acids Res.
  doi: 10.1093/nar/gkab1061
– volume: 83
  start-page: 725
  year: 2023
  ident: 10.1016/j.tips.2024.10.003_bb0015
  article-title: Omaveloxolone: first approval
  publication-title: Drugs
  doi: 10.1007/s40265-023-01874-9
– volume: 81
  start-page: 1445
  year: 2021
  ident: 10.1016/j.tips.2024.10.003_bb0020
  article-title: Ibrexafungerp: first approval
  publication-title: Drugs
  doi: 10.1007/s40265-021-01571-5
– volume: 4
  start-page: 1256
  year: 2021
  ident: 10.1016/j.tips.2024.10.003_bb0090
  article-title: Large scale chemical language representations capture molecular structures and properties
  publication-title: Nat. Mach. Intell.
  doi: 10.1038/s42256-022-00580-7
SSID ssj0003321
Score 2.4848936
SecondaryResourceType review_article
Snippet AbstractTriterpenes are structurally complex natural products with promising therapeutic properties. Recalcitrance to chemical synthesis has hindered their use...
Triterpenes are structurally complex natural products with promising therapeutic properties. Recalcitrance to chemical synthesis has hindered their use in drug...
SourceID proquest
pubmed
crossref
elsevier
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 964
SubjectTerms Advanced Basic Science
Animals
Biological Products - chemistry
Biological Products - pharmacology
Drug Discovery - methods
Humans
Triterpenes - chemistry
Triterpenes - pharmacology
Title Advances in triterpene drug discovery
URI https://www.clinicalkey.es/playcontent/1-s2.0-S016561472400213X
https://www.ncbi.nlm.nih.gov/pubmed/39482199
https://www.proquest.com/docview/3123072780
Volume 45
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lj9MwELZgkdBeEG_KS0GCvXRTrR-Jm-OCgBUSaIW6UsXFSmwXsYI0atrDcuC3M-NHXB5FwCVq7TSp5rPH45lvxoQ8lay0i0bI3Fpb5EIKk9e6WsDXQtRYD0q4LP6378qTM_FmXszTKY4uu2TdTPTX3-aV_A-q0Aa4YpbsPyA7PBQa4DPgC1dAGK5_hfGxD-A7SisW1berDlTX2Kw2HzHyopGe-UPYNjFgu1SyOiVGau-Dfe_Op1-NrZlsOQpeL42pPRH-w9LF158ntqFjLXvv93b2T3CaeuZkCOAHFwMTIdfOrRBeLU4lB1XkC4tEvenLQMbxQbe0YOULk_-inb2j4BwW4w4rpTMxccQ6vn0zSLj74vDilZiCPq3SSjXwB2PXZXKFwfYA9dvkW6L2cM5oSJDyXL6fX7hPrsZH7LJHdu03nN0xu06uhQ1DduzRv0Eu2fYmOTj18F0cZrOUQNcfZgfZaQL24hZ5FodI9qnN0hDJcIhkwxC5Tc5evZy9OMnDyRi5hv3-Oue64gYsOb6gRaMlhsalrURjYavEbGVLDb2igv6yKBbQKbgBu7ymjWxAh2t-h-y1y9beI1kt6rJsKg2TshEGzFW0WY2hQtbMwHtGhEb5KB3KxuPpJZ9V5AeeKxSvQvFiG4h3RMbDbzpfNOWPd8sodhXTgWEBs32Yab2iqmfqCImIJRaulch7ZpTPR-RJREmBVsRQV93a5aZXnGKCA5PToxG56-Eb_klE_v7OngdkP02Dh2RvvdrYR2B7rpvHbqB9B7IGf1o
linkProvider Elsevier
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Advances+in+triterpene+drug+discovery&rft.jtitle=Trends+in+pharmacological+sciences+%28Regular+ed.%29&rft.au=Goddard%2C+Zo%C3%AB+R&rft.au=Searcey%2C+Mark&rft.au=Osbourn%2C+Anne&rft.date=2024-11-01&rft.eissn=1873-3735&rft.volume=45&rft.issue=11&rft.spage=964&rft_id=info:doi/10.1016%2Fj.tips.2024.10.003&rft_id=info%3Apmid%2F39482199&rft.externalDocID=39482199
thumbnail_m http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F01656147%2FS0165614723X00121%2Fcov150h.gif